1434141-79-3 Usage
Uses
Used in Organic Synthesis:
Tert-butyl (3-hydroxy-2,2-dimethylcyclobutyl)carbamate is used as a protecting group for hydroxyl groups during chemical reactions to prevent unwanted side reactions or interactions. Its stability and the ability to be easily removed under mild conditions make it a popular choice for protecting hydroxyl groups in various organic synthesis processes.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, tert-butyl (3-hydroxy-2,2-dimethylcyclobutyl)carbamate is used as a protecting group for hydroxyl groups in the synthesis of complex organic molecules, including drug candidates. Its use ensures the successful synthesis of target compounds by preventing unwanted side reactions, thereby facilitating the development of new and effective pharmaceuticals.
Used in Chemical Research:
Tert-butyl (3-hydroxy-2,2-dimethylcyclobutyl)carbamate is also utilized in chemical research as a protecting group for hydroxyl groups in the synthesis and study of novel organic compounds. Its application allows researchers to explore the reactivity and properties of these compounds without interference from side reactions, contributing to the advancement of chemical knowledge and the discovery of new chemical entities.
Check Digit Verification of cas no
The CAS Registry Mumber 1434141-79-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,4,1,4 and 1 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1434141-79:
(9*1)+(8*4)+(7*3)+(6*4)+(5*1)+(4*4)+(3*1)+(2*7)+(1*9)=133
133 % 10 = 3
So 1434141-79-3 is a valid CAS Registry Number.
1434141-79-3Relevant academic research and scientific papers
SUBSTITUTED DIAMINOPYRIMIDYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
-
Paragraph 0209, (2015/07/02)
Provided herein are diaminopyrimidyl Compounds having the following structures: wherein X, L, R1, and R2 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidyl Compound, and methods for treating or preventing PKC-theta-mediated disorders, or a condition treatable or preventable by inhibition of a kinase, for example, PKC-theta.
